Harmony Biosciences Holdings, Inc. HRMY Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $215.39M-11.6% | $243.78M+1.8% | $239.46M+19.4% | $200.49M+8.5% | $184.73M-8.2% | ||
| $44.51M-35.1% | $68.55M+14.9% | $59.65M+56.3% | $38.15M+19.3% | $31.99M-41.2% | ||
| $170.88M-2.5% | $175.23M-2.5% | $179.81M+10.8% | $162.34M+6.3% | $152.74M+4.0% | ||
| 79.3%+7.5pp | 71.9%-3.2pp | 75.1%-5.9pp | 81%-1.7pp | 82.7%+9.7pp | ||
| $69.38M+39.0% | $49.93M-9.1% | $54.96M+9.6% | $50.16M+45.2% | $34.54M-0.4% | ||
| $31.69M+8.6% | $29.18M-1.3% | $29.55M-1.7% | $30.07M-2.1% | $30.71M+11.3% | ||
| $32.51M-43.5% | $57.56M+93.1% | $29.81M-12.1% | $33.92M+8.6% | $31.24M+8.2% | ||
| $133.58M-2.3% | $136.67M+19.6% | $114.32M+0.1% | $114.16M+18.3% | $96.49M+5.9% | ||
| $133.58M-2.3% | $136.67M+19.6% | $114.32M+0.1% | $114.16M+18.3% | $96.49M+5.9% | ||
| $37.29M-3.3% | $38.56M-41.1% | $65.49M+35.9% | $48.18M-14.3% | $56.25M+0.9% | ||
| 17.3%+1.5pp | 15.8%-11.5pp | 27.3%+3.3pp | 24%-6.4pp | 30.4%+2.8pp | ||
| $3.23M-8.8% | $3.55M-2.1% | $3.62M-0.7% | $3.65M-5.0% | $3.84M-8.9% | ||
| -$127K-21.0% | -$105K+0.9% | -$106K+45.1% | -$193K+30.1% | -$276K— | ||
| $39.69M-2.6% | $40.76M-39.6% | $67.49M+36.0% | $49.64M-13.2% | $57.18M+1.8% | ||
| $7.2M-60.6% | $18.27M+9.9% | $16.63M+68.6% | $9.86M-15.1% | $11.62M+73.9% | ||
| $32.49M+44.5% | $22.49M-55.8% | $50.87M+27.9% | $39.78M-12.7% | $45.56M-7.9% | ||
| 15.1%+5.9pp | 9.2%-12.0pp | 21.2%+1.4pp | 19.8%-4.8pp | 24.7%+0.1pp | ||
| $0.55+41.0% | $0.39-55.2% | $0.87+27.9% | $0.68-12.8% | $0.78-8.2% | ||
| $0.56+40.0% | $0.40-54.5% | $0.88+27.5% | $0.69-12.7% | $0.79-9.2% | ||
| 58.8M+0.4% | 58.5M-0.3% | 58.7M+0.5% | 58.4M-0.2% | 58.5M+1.1% | ||
| 57.8M+0.6% | 57.5M-0.1% | 57.6M+0.1% | 57.5M+0.3% | 57.3M+0.7% | ||
| $31.73M+41.2% | $22.48M-55.9% | $50.98M+28.2% | $39.77M-13.1% | $45.74M-6.7% | ||
| $5.76M-1.7% | $5.85M+2.2% | $5.73M+8.2% | $5.3M+5.0% | $5.04M+12.7% | ||
| -$127K-21.0% | -$105K+0.9% | -$106K+45.1% | -$193K+30.1% | -$276K— | ||
| $215.39M-11.6% | $243.78M+1.8% | $239.46M+19.4% | $200.49M+8.5% | $184.73M-8.2% | ||
| $37.29M-3.3% | $38.56M-41.1% | $65.49M+35.9% | $48.18M-14.3% | $56.25M+0.9% | ||
| $43.26M-2.8% | $44.52M-37.7% | $71.46M+32.0% | $54.15M-13.0% | $62.21M+0.8% | ||
| $43.26M-2.8% | $44.52M-37.7% | $71.46M+32.0% | $54.15M-13.0% | $62.21M+0.8% | ||
| 20.1%+1.8pp | 18.3%-11.6pp | 29.8%+2.8pp | 27%-6.7pp | 33.7%+3.0pp | ||
| $37.29M-3.3% | $38.56M-41.1% | $65.49M+35.9% | $48.18M-14.3% | $56.25M+0.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Harmony Biosciences Holdings, Inc.'s profit margins?
- Gross margin is 76.5% and operating margin is 21.1%, with a 16.2% net margin.
- Where does Harmony Biosciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.